FDC Ltd.
Snapshot View

View in App

Prices View details >>

260.00 0.00

29 September 2022, 12:57:58 PM
Volume: 59,830

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.fdcindia.com
Market Cap 4,285.46 Cr.
Enterprise Value(EV) 4,269.31 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 11.41 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 22.64 Trailing Twelve Months Ending 2022-06
Industry PE 30.82 Trailing Twelve Months Ending 2022-06
Book Value / Share 122.18 Trailing Twelve Months Ending 2022-06
Price to Book Value 2.11 Calculated using Price: 258.30
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 16.59 Cr. 165,910,084 Shares
FaceValue 1
Company Profile
FDC Limited is among India's leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialised formulations, and among the world's foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Over its long history of 85 years, the Company has maintained a distinguished reputation for high-quality, affordable products and built a market-leading brand portfolio.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-6.42%
1 Month
-0.74%
3 Month
+10.29%
6 Month
-0.88%
1 Year
-26.00%
2 Year
-28.85%
5 Year
+39.34%
10 Year
+190.50%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 16.63 16.64 16.76 16.02 13.67 12.63 16.10 18.36 11.71
Return on Capital Employed (%) 27.12 23.02 23.15 21.51 19.04 17.64 21.63 23.74 15.78
Return on Assets (%) 13.26 13.34 14.01 12.00 9.05 8.30 10.48 11.85 7.59

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 784 845 936 1,082 1,270 1,276 1,445 1,547 1,734 1,957
Non Curr. Liab. 31 31 24 20 217 211 229 315 300 391
Curr. Liab. 154 196 188 163 389 480 497 565 622 690
Minority Int. 0 0
Equity & Liab. 970 1,072 1,148 1,266 1,876 1,968 2,172 2,427 2,655 3,038
Non Curr. Assets 558 619 646 742 958 977 1,113 1,181 1,303 1,620
Curr. Assets 411 452 502 523 918 991 1,058 1,245 1,352 1,418
Misc. Exp. not W/O 1 0
Total Assets 970 1,072 1,148 1,266 1,876 1,968 2,172 2,427 2,655 3,038

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 846 889 994 1,014 1,075 1,091 1,344 1,333 1,528 1,575
Other Income 42 46 39 50 51 43 69 97 76 72
Total Income 888 935 1,033 1,064 1,126 1,134 1,413 1,430 1,604 1,647
Total Expenditure -641 -691 -766 -770 -848 -860 -1,051 -999 -1,274 -1,359
PBIDT 246 244 268 294 278 274 362 431 330 288
Interest -3 -2 -1 -1 -1 -1 -3 -3 -3 -3
Depreciation -25 -39 -34 -35 -35 -33 -37 -38 -37 -37
Taxation -83 -56 -63 -63 -67 -67 -80 -87 -73 -59
Exceptional Items -6 -1 -2
PAT 135 148 169 188 174 172 241 301 216 189
Minority Interest 0 0 0
Share Associate 0 0 0 -2 -1 0
Other Related Items
Consolidated Net Profit 135 148 169 189 174 170 240 301 216 189
Adjusted EPS 8 8 9 11 10 10 14 18 13 11

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 150 150 128 174 154 150 112 250 207 162
Cash Fr. Inv. -107 -55 -89 -73 -144 20 -120 -98 -77 -145
Cash Fr. Finan. -63 -75 -48 -97 0 -169 0 -142 -129 -10
Net Change -20 19 -9 4 11 1 -8 10 1 7
Cash & Cash Eqvt 4 23 15 16 27 28 20 30 30 38

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 69.24 69.24 69.35 69.35 69.35 69.35 69.36 69.36 69.50
Public 30.76 30.76 30.65 30.65 30.65 30.65 30.64 30.64 30.51
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 23 Sep 2022
Annual General Meeting
Please find enclosed the details of the Voting Results along with Scrutinizer's Report of the 82nd Annual General Meeting (AGM) of the Company held on September 22, 2022 at 10.00 a.m. through Video Conferencing (VC)/ other Audio Visual Means (OAVM) in the format as prescribed under Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.Kindly take the above on record.
Fri, 23 Sep 2022
Annual General Meeting
Please find enclosed the details of the Voting Results along with Scrutinizer's Report of the 82nd Annual General Meeting (AGM) of the Company held on September 22, 2022 at 10.00 a.m. through Video Conferencing (VC)/ other Audio Visual Means (OAVM) in the format as prescribed under Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.Kindly take the above on record.
Fri, 23 Sep 2022
General updates
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (???SEBI Listing Regulations???), we wish to inform you that the Appointment of Mr. Vijay S. Maniar (DIN: 00750905) as an Non-Executive and Independent Director of the Company, with effect from August 04, 2022 till August 3, 2027 has been approved by the shareholders at the 82nd Annual General Meeting (???AGM???) of the Company, held on Thursday, September 22, 2022, through video conferencing. Details required under Regulation 30 of the SEBI Listing Regulations read along with SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015 are enclosed herewith as ???Annexure A???.This intimation will also be available on website of the Company at www.fdcindia.com Request you to kindly take this intimation on record and acknowledge.

Technical Scans View Details >>

Wed, 28 Sep 2022
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
MFI Trending Down MFI Trending Down
CCI Oversold Zone CCI Oversold Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,222.96 935.50 +1.9%
Divi's Laboratories Ltd. 98,114.53 3,731.95 +0.8%
Cipla Ltd. 88,495.80 1,113.80 +1.5%
Dr. Reddy's Laboratories Ltd. 71,034.40 4,376.00 +2.5%
Apollo Hospitals Enterprise Ltd. 61,344.29 4,385.50 +2.7%
Torrent Pharmaceuticals Ltd. 50,536.67 1,531.60 +2.5%
Alkem Laboratories Ltd. 39,477.37 3,189.70 -3.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.55 935.50 +1.9%
Divi's Laboratories Ltd. Consolidated 2022-06 31.60 3,731.95 +0.8%
Cipla Ltd. Consolidated 2022-06 35.56 1,113.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.75 4,376.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.44 4,385.50 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.09 1,531.60 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-06 30.25 3,189.70 -3.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.39 935.50 +1.9%
Divi's Laboratories Ltd. Consolidated 2022-06 7.89 3,731.95 +0.8%
Cipla Ltd. Consolidated 2022-06 4.12 1,113.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.51 4,376.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.32 4,385.50 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 7.91 1,531.60 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-06 4.50 3,189.70 -3.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 935.50 +1.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,731.95 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,113.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,376.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,385.50 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,531.60 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-03 0.30 3,189.70 -3.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 935.50 +1.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,731.95 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,113.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,376.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,385.50 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,531.60 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,189.70 -3.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 935.50 +1.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,731.95 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,113.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,376.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,385.50 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,531.60 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,189.70 -3.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 935.50 +1.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,731.95 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,113.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,376.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,385.50 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,531.60 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-03 10,634.19 3,189.70 -3.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 935.50 +1.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,731.95 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,113.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,376.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,385.50 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,531.60 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-03 1,680.32 3,189.70 -3.3%

FAQ's On FDC Ltd.

What is FDC share price?
Can I buy FDC shares now?
What is the Market Cap of FDC?
What are the key metrics to analyse FDC?
What is the 52 Week High and Low of FDC?
What is the trend of FDC share price?